LC/MS-Based Global Metabolomic Identification of Serum Biomarkers Differentiating Hepatocellular Carcinoma from Chronic Hepatitis B and Liver Cirrhosis-Reference-Cited by-同舟云学术

LC/MS-Based Global Metabolomic Identification of Serum Biomarkers Differentiating Hepatocellular Carcinoma from Chronic Hepatitis B and Liver Cirrhosis

Published:2021-01-04 Issue:2 Volume:6 Page:1160-1170
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Pan Hong Y.¹,Wu Qing Q.¹²,Yin Qiao Q.¹³,Dai Yi N.¹^ORCID,Huang Yi C.¹,Zheng Wei¹,Hui Tian C.¹³,Chen Mei J.¹,Wang Ming S.¹,Zhang Jia J.¹,Huang Hai J.¹,Tong Yong X.¹^ORCID

Affiliation:

1. Department of Infectious Diseases, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, No. 158 Shangtang Road, Hangzhou, Zhejiang 310014, China

2. The Second Clinical Medical College, Zhejiang Chinese Medical University, No. 548 Binwen Road, Hangzhou, Zhejiang 310053, China

3. Bengbu Medical College, No. 2600 Donghai Road, Bengbu, Anhui 233030, China

Funder

Ministry of Science and Technology of the People's Republic of China

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acsomega.0c04259

Reference41 articles.

1. Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis